Literature DB >> 2503278

Spontaneous and LPS-stimulated production of intracellular IL-1 beta by synovial macrophages in rheumatoid arthritis is inhibited by IFN-gamma.

S Ruschen1, G Lemm, H Warnatz.   

Abstract

In the peripheral blood (PB) as well as the synovial fluid (SF) of rheumatoid arthritis (RA) patients significantly elevated levels of interleukin 1 beta (IL-1 beta) were determined compared to controls by means of a sensitive and specific ELISA (median values: 280 pg/ml and 325 pg/ml vs. less than 20 pg/ml). In 12-h cell cultures of adherent cells, significantly increased spontaneous intracellular IL-1 beta production was determined in SF macrophage (SFM phi) cultures of RA patients compared to PB monocyte (PBMo) cultures of controls (median values: 91.0 ng/10(6) cells vs. 31.5 ng/10(6) cells). However, secretion must be elicited by additional stimulation with lipopolysaccharide (LPS). Interferon-gamma (IFN-gamma) significantly inhibited the spontaneous intracellular IL-1 beta production in SFM phi 12-h cultures of RA patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503278      PMCID: PMC1541833     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  [Use of recombinant human gamma interferon in patients with rheumatoid arthritis].

Authors:  M Seitz; G Manz; M Franke
Journal:  Z Rheumatol       Date:  1986 May-Jun       Impact factor: 1.372

2.  Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor.

Authors:  G S Firestein; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1987-08

3.  Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis.

Authors:  G Lemm; H Warnatz
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

4.  Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid.

Authors:  P Miossec; C A Dinarello; M Ziff
Journal:  Arthritis Rheum       Date:  1986-04

5.  Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate.

Authors:  P J Knudsen; C A Dinarello; T B Strom
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

6.  Differential effects of interferon-alpha and interferon-gamma on interleukin 1 secretion by monocytes.

Authors:  T L Gerrard; J P Siegel; D R Dyer; K C Zoon
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

7.  Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2.

Authors:  J Kaye; S Gillis; S B Mizel; E M Shevach; T R Malek; C A Dinarello; L B Lachman; C A Janeway
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

8.  Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro.

Authors:  C A Dinarello; T Ikejima; S J Warner; S F Orencole; G Lonnemann; J G Cannon; P Libby
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

9.  Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes.

Authors:  F Arenzana-Seisdedos; J L Virelizier; W Fiers
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

10.  Chemical characterization of an interleukin-1-inducing substance derived from human mixed leukocyte reactions: IL-1-inducing substance is not gamma interferon.

Authors:  C A Dinarello; E F Kent
Journal:  Yale J Biol Med       Date:  1985 Mar-Apr
View more
  5 in total

1.  Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production.

Authors:  Seth L Masters; Lisa A Mielke; Ann L Cornish; Caroline E Sutton; Joanne O'Donnell; Louise H Cengia; Andrew W Roberts; Ian P Wicks; Kingston H G Mills; Ben A Croker
Journal:  EMBO Rep       Date:  2010-07-02       Impact factor: 8.807

2.  Reduction of tumor necrosis factor alpha and interleukin-1 beta levels in human synovial tissue by interleukin-4 and glucocorticoid.

Authors:  A Bendrups; A Hilton; A Meager; J A Hamilton
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

3.  Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls.

Authors:  S Ruschen; W Stellberg; H Warnatz
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

4.  Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis. German Lymphokine Study Group.

Authors: 
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

5.  Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1β production from human synovial fibroblasts.

Authors:  Kiyoshi Migita; Tomohiro Koga; Kenshi Satomura; Masahiro Izumi; Takafumi Torigoshi; Yumi Maeda; Yasumori Izumi; Yuka Jiuchi; Taiichiro Miyashita; Satoshi Yamasaki; Yoshihiro Aiba; Atsumasa Komori; Minoru Nakamura; Satoru Motokawa; Atsushi Kawakami; Tadashi Nakamura; Hiromi Ishibashi
Journal:  Arthritis Res Ther       Date:  2012-05-18       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.